EU - OHE - Page 72

Office of Health Economics

Leading intellectual authority on global health economics

Search publications, topics, authors and more

Newsletter SignupSubscribe

News & Insights

News
Events
Insights
Bulletin

News
Events
Insights
Bulletin

News & Insights

News
Events
Insights
Bulletin

Newsletter SignupSubscribe

News
Events
Insights
Bulletin

Search publications, topics, authors and more

Research & Publications
News & Insights
Education
Innovation Policy Prize

Events
About Us
OHE Experts
Join OHE
Contact Us

Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:

Antimicrobial Resistance (AMR)
Biosimilars
Cell and Gene Therapies
Chronic Diseases
Combination Therapies
COVID-19 Research
Digital Health
Drug Development/R&D
Emerging Markets
EQ-5D and PROMs
Health Care Systems
Health Data and Statistics
Health Technology Assessment
Precision Medicine
Prevention
Real-World Evidence
Sustainability
Use of Medicines
Value-Based Pricing
Vaccine Research

Economics of Innovation
Measuring and Valuing Outcomes
Policy, Organisation and Incentives in Health Systems
Value, Affordability and Decision Making

News & Insights

News
Events
Insights
Bulletin

Education

Education Hub
OHE Graduate School
EVIA Programme

Innovation Policy Prize

The Prize Fund
2024 Prize Fund
2022 Prize Fund

Search publications, topics, authors and more

Latest Research & Publications

Injury and Trauma

Infants at Risk

Health Care Systems
Policy, Organisation and…
Healthcare Delivery

Personal Health Services: A Perspective of the General Medical & the Pharmaceutical Services

Infectious Diseases

Price of Poliomyelitis

Health Care Systems
Policy, Organisation and…
Health Policy and Regulation

Hospital Costs in Perspective

Health Care Systems
Policy, Organisation and…
Healthcare Delivery

Health Services in Western Europe

Infectious Diseases

Pneumonia in Decline

Policy, Organisation and…

Lives of Our Children: a Study in Childhood Mortality

All Publications

Filter by:

Antimicrobial Resistance (AMR)

Biosimilars

Cell and Gene Therapies

Chronic Diseases

Combination Therapies

COVID-19 Research

Digital Health

Drug Development/R&D

Emerging Markets

EQ-5D and PROMs

Health Care Systems

Health Data and Statistics

Health Technology Assessment

Precision Medicine

Prevention

Real-World Evidence

Sustainability

Use of Medicines

Value-Based Pricing

Vaccine Research

Economics of Innovation

Measuring and Valuing Outcomes

Policy, Organisation and Incentives in Health Systems

Value, Affordability and Decision Making
News

Events

Insights

Bulletin
Education Hub

OHE Graduate School

EVIA Programme
The Prize Fund

2024 Prize Fund

2022 Prize Fund

Events
About Us
OHE Experts
Join OHE
Contact Us

Newsletter SignupSubscribe

Filter results by

Theme

Select the product option you would like to filter Theme

Economics of Innovation Measuring and Valuing Outcomes Policy, Organisation and Incentives in Health Systems Value, Affordability, and Decision Making

Topic

Select the product option you would like to filter Topic

Antimicrobial Resistance (AMR) Biosimilars Cell and Gene Therapies Chronic Diseases Combination Therapies COVID-19 Research Dementia Digital Health Drug Development/R&D Emerging Markets EQ-5D and PROMs Health Care Systems Health Data and Statistics Health Technology Assessment (HTA) Innovation Policy Prize OHE Consulting Precision Medicine Prevention Real World Evidence (RWE) Research Sustainability Use of Medicines Vaccines Value-Based Pricing

Tag

Select the product option you would like to filter Tag

Adult Immunisation Alzheimer's Cancer Cardiovascular Disorders Care-givers Caring burden Cervical Cancer Clinical Outcomes Commentary Competition Dermatology Determining Value Drug Shortages Economic Evaluation Egypt Epidemiology and Public Health Epilepsy Gene therapies Generics Greece Haemophilia Health Policy and Regulation Healthcare Delivery Healthcare Expenditure Healthcare Funding Healthcare System Pressure (HCSP) India Infectious Diseases Inflation Reduction Act Injury and Trauma Innovation Israel Market Access Mental Health Pharmaceutical Industry Plant-based Policy Analysis Pricing and Reimbursement Primary Care Quality of Care Quality of Life Rare and Orphan Diseases Research Funding Resource Allocation Saudi Arabia Slovak Republic Supply of Medicine Türkiye Unmet Need Vaccines Value based pricing Webinar

Date 1

Select the product option you would like to filter Date

Date From

Month From

Year From

Date To

Month To

Year To

Author

Select the product option you would like to filter Author

Search authors

Lishani Ramanayake Sukanya Subramaniyan Brittany Darrow Henry Fong Yi Wang Chittawan Poonsiri Manit Sittimart Sarin Kc Hannah Hussain Dr. Sabine Vogler

Content Type

Select the product option you would like to filter Content Type

news story insight events podcast bulletin publications

Health Care Systems
Policy, Organisation and…

Compendium of Health Statistics

Clinical Outcomes

QALYs versus Experience: A Perspective from Experimental Economics

Health Care Systems
Measuring and Valuing Outcomes
Economic Evaluation

NHS Outcomes, Performance and Productivity

#image_title

Drug Development/R&D
Value, Affordability, and…
Mental Health

Medical Research: What’s It Worth?

Health Technology Assessment…
Value, Affordability, and…

New Guidelines for Economic Evaluation in Germany and the United Kingdom: Are We Any Closer to Developing International Standards?

Biosimilars
Economics of Innovation
Competition

The Market for Biosimilars: Evolution and Policy Options

Policy, Organisation and…
Health Policy and Regulation

Health Care Services and the Single European Market

Health Care Systems
Policy, Organisation and…

Sixty Years of the NHS: Changes in Demographics, Expenditure, Workforce and Family Services

Measuring and Valuing Outcomes
Market Access

Challenges and Opportunities for Improving Benefit-Risk Assessment of Pharmaceuticals from an Economic Perspective

Health Policy and Regulation

European Medicines Pricing and Reimbursement: Now and the Future

Vaccines
Determining Value

The New Global Economics of Vaccines: Will the Scientific Potential Be Realised?

Measuring and Valuing Outcomes

The Economics of Health Care

Drug Development/R&D
Economics of Innovation
Infectious Diseases

Donor Investment Choices: Modeling the Value for Money of Investing in Product Development, Public Private Parnerships as Compared to Other Health Care and Non-Health Care Interventions

Emerging Markets
Economics of Innovation
Infectious Diseases

Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance

Health Technology Assessment…
Measuring and Valuing Outcomes

Three Challenges to Achieving Better Analysis for Better Decisions: Generalisability, Complexity and Thresholds

Leading intellectual authority on global health economics

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Cookies Policy

An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Twitter

Facebook

Copy

Share on Mastodon

Enter your Mastodon instance URL (optional)

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Enable or Disable Cookies

Please enable Strictly Necessary Cookies first so that we can save your preferences!

News & Insights

Latest Research & Publications

Infants at Risk

Venereal Diseases

Personal Health Services: A Perspective of the General Medical & the Pharmaceutical Services

Price of Poliomyelitis

Hospital Costs in Perspective

Health Services in Western Europe

Pneumonia in Decline

Lives of Our Children: a Study in Childhood Mortality

All Publications

Filter results by

Compendium of Health Statistics

QALYs versus Experience: A Perspective from Experimental Economics

NHS Outcomes, Performance and Productivity

Medical Research: What’s It Worth?

New Guidelines for Economic Evaluation in Germany and the United Kingdom: Are We Any Closer to Developing International Standards?

The Market for Biosimilars: Evolution and Policy Options

Health Care Services and the Single European Market

Sixty Years of the NHS: Changes in Demographics, Expenditure, Workforce and Family Services

Challenges and Opportunities for Improving Benefit-Risk Assessment of Pharmaceuticals from an Economic Perspective

Applied Econometrics for Health Economists: A Practical Guide

European Medicines Pricing and Reimbursement: Now and the Future

The New Global Economics of Vaccines: Will the Scientific Potential Be Realised?

The Economics of Health Care

Donor Investment Choices: Modeling the Value for Money of Investing in Product Development, Public Private Parnerships as Compared to Other Health Care and Non-Health Care Interventions

Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance

Three Challenges to Achieving Better Analysis for Better Decisions: Generalisability, Complexity and Thresholds

Share on Mastodon